The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Approval of the FCA condition

21 Jan 2022 07:00

RNS Number : 2098Z
Ince Group PLC (The)
21 January 2022
 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION (INCLUDING THE UNITED STATES) WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

 

21 January 2022

 

Recommended All Share Offer

for

Arden Partners plc ("Arden")

by

The Ince GrouP plc ("Ince")

 

Approval of the FCA condition

 

Further to Ince's announcement on 19 January 2022, the directors of Ince are pleased to report that the FCA has approved the change of control of Arden upon the completion of Ince's all-share offer to acquire the issued and to be issued share capital of Arden announced on 26 October 2021 (the "Acquisition"). The Acquisition is to be effected through a court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006 (the "Scheme").

 

The Scheme was approved by the requisite majorities of the Arden shareholders at meetings held on 19 January 2022, following which completion of the Scheme and the Acquisition remained subject to the satisfaction or (where applicable) waiver of the remaining Conditions, as set out in the Scheme Document published on 20 December 2021. These included the approval by the FCA of the Change of Control in accordance with section 185 of the FSMA; the London Stock Exchange determining that, following the Change of Control, Arden remains eligible to act as a Nominated Adviser in accordance with the AIM Rules for Nominated Advisers; and the sanction of the Scheme by the Court.

The FCA has now approved the Change of Control in accordance with section 185 of the FSMA. This approval remains effective subject to completion of the Acquisition within three months from 20 January 2022, after which an extension will need to be requested.

 

The current expected timetable of principal events for the implementation of the Scheme remains as set out in the Scheme Document and in Arden's announcement on 19 January 2022.

 

Capitalised terms used but not otherwise defined in this announcement have the meanings given to them in the Scheme Document.

 

Enquiries:

 

The Ince Group plc

Adrian Biles, Group Chief Executive

investorrelations@incegd.com

Simon Oakes, Chief Financial Officer

Allenby Capital Limited - Nominated Adviser

+44 (0) 20 3328 5656

Jeremy Porter / Piers Shimwell, Corporate Finance

Arden Partners plc - Financial Adviser and Broker

+44 (0) 20 7614 5900

Paul Shackleton, Corporate Finance

John Llewellyn Lloyd, Corporate Finance

Louisa Waddell, Corporate Finance

Simon Johnson, Equity Sales

Williams Nicolson - Financial PR

+44 (0) 7767 345 563

Steffan Williams / Fraser Schurer-Lewis

ince@williamsnicolson.com

 

About The Ince Group plc

The Ince Group is a dynamic international legal and professional services business with offices in nine countries across Europe, Asia and the Middle East. With over 700 people, The Ince Group delivers legal advice, strategic guidance and business solutions to clients ranging from the world's oldest and biggest businesses operating across numerous industries to ultra-high net worth individuals. Through its entrepreneurial culture and "one firm" approach, the business offers its clients over 150 years of experience, insight and relationships. The Group is driven by a unique team of passionate people whose broad expertise and deep sector specialisms provide their clients with solutions to all their complex legal and strategic needs.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEADFFAAEAEEA
Date   Source Headline
3rd Jul 201712:45 pmRNSHolding(s) in Company
3rd Jul 201712:44 pmRNSHolding(s) in Company
30th Jun 20178:56 amRNSDirector/PDMR Shareholding
29th Jun 201711:07 amRNSResult of Meeting and Total Voting Rights
12th Jun 20178:21 amRNSResult of Placing
12th Jun 20177:01 amRNSProposed Placing
12th Jun 20177:00 amRNSInterim Results - Six Months Ended 30 April 2017
25th May 20177:00 amRNSDirectorate Changes and Possible Fundraising
13th Apr 201711:50 amRNSForm 8.5 (EPT/NON-RI)
3rd Apr 201711:50 amRNSForm 8.5 (EPT/NON-RI)
31st Mar 201711:50 amRNSForm 8.5 (EPT/NON-RI)
15th Mar 20178:21 amRNSPossible offer by Dolphin for FIH Group
9th Mar 201712:17 pmRNSResult of AGM
9th Mar 201710:57 amRNSAGM Statement
13th Feb 201711:31 amRNSBlock Listing Six Monthly Return
7th Feb 20172:40 pmRNSPublication of Annual Report and Notice of AGM
3rd Feb 201711:28 amRNSTransaction in Own Shares and Total Voting Rights
1st Feb 20172:09 pmRNSProposed Award of Share Options
26th Jan 20177:00 amRNSPreliminary Results - Year Ended 31 October 2016
6th Jan 201711:50 amRNSForm 8.5 (EPT/NON-RI)
20th Dec 201611:50 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 201612:30 pmRNSForm 8.5 (EPT/NON-RI) AMENDMENT
1st Dec 201611:50 amRNSForm 8.5 (EPT/NON-RI)
30th Nov 201611:50 amRNSForm 8.5 (EPT/NON-RI)
21st Nov 201612:17 pmRNSForm 8.5 (EPT/NON-RI)
2nd Nov 201611:50 amRNSForm 8.5 (EPT/NON-RI)
28th Oct 201612:27 pmRNSHolding(s) in Company
28th Oct 201612:12 pmRNSHolding(s) in Company
28th Oct 201611:03 amRNSHolding(s) in Company
28th Oct 201610:44 amRNSHolding(s) in Company
28th Oct 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Oct 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Oct 20167:00 amRNSPersonnel Change
6th Oct 201611:50 amRNSForm 8.5 (EPT/NON-RI)
4th Oct 201611:50 amRNSForm 8.5 (EPT/NON-RI)
26th Sep 201611:49 amRNSForm 8.5 (EPT/NON-RI)
20th Sep 201611:50 amRNSForm 8.5 (EPT/NON-RI)
16th Sep 20162:19 pmRNSForm 8.5 (EPT/NON-RI)
19th Aug 201612:08 pmRNSHolding(s) in Company
12th Aug 201611:25 amRNSBlocklisting Six Monthly Return
11th Aug 201610:10 amRNSForm 8.5 (EPT/NON-RI)
2nd Aug 20167:00 amRNSDirector/PDMR Shareholding
1st Aug 20167:30 amRNSChange of Name of Nominated Adviser
28th Jul 20167:00 amRNSInterim Results - Six Months Ended 30 April 2016
21st Jul 201611:50 amRNSForm 8.5 (EPT/NON-RI)
11th Jul 201611:23 amRNSForm 8.5 (EPT/NON-RI)
15th Jun 201611:50 amRNSForm 8.5 (EPT/NON-RI)
9th Jun 20169:44 amRNSForm 8.5 (EPT/NON-RI)
7th Jun 201611:50 amRNSForm 8.5 (EPT/NON-RI)
3rd Jun 201611:50 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.